Biotech Digest – KTOV buys stake, JNJ reports positive results, NVS receives CE mark
October 09, 2017 at 09:52 AM EDT
Kitov Pharmaceuticals announced that it has acquired an additional 27% stake in privately held TyrNovo, a developer of small molecule oncology drugs.
